Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China

C Qin, L Zhou, Z Hu, S Zhang, S Yang… - Clinical infectious …, 2020 - academic.oup.com
Abstract Background In December 2019, coronavirus 2019 (COVID-19) emerged in Wuhan
and rapidly spread throughout China. Methods Demographic and clinical data of all …

[HTML][HTML] COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes

B Bigdelou, MR Sepand, S Najafikhoshnoo… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …

[HTML][HTML] Exploring the role of immune system and inflammatory cytokines in SARS-CoV-2 induced lung disease: a narrative review

C Tirelli, M De Amici, C Albrici, S Mira, G Nalesso, B Re… - Biology, 2023 - mdpi.com
Simple Summary Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
responsible for the pandemic coronavirus disease-2019 (COVID-19), which can lead to …

[HTML][HTML] Immunopathogenesis and treatment of cytokine storm in COVID-19

JS Kim, JY Lee, JW Yang, KH Lee, M Effenberger… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract Severe coronavirus disease 2019 (COVID-19) is characterized by systemic hyper-
inflammation, acute respiratory distress syndrome, and multiple organ failure. Cytokine …

[HTML][HTML] Deciphering SARS-CoV-2 virologic and immunologic features

G Lebeau, D Vagner, E Frumence, F Ah-Pine… - International journal of …, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated
pathology, COVID-19, have been of particular concerns these last months due to the …

[HTML][HTML] Immunomodulation for severe COVID-19 pneumonia: the state of the art

Y Zhang, Y Chen, Z Meng - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 has become a worldwide pandemic caused by the novel coronavirus named
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 …

[HTML][HTML] Immunological and inflammatory profiles in mild and severe cases of COVID-19

JW Song, C Zhang, X Fan, FP Meng, Z Xu, P Xia… - Nature …, 2020 - nature.com
Abstract COVID-19 is associated with 5.1% mortality. Although the virological,
epidemiological, clinical, and management outcome features of COVID-19 patients have …

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and …

J Wang, M Jiang, X Chen… - Journal of Leucocyte …, 2020 - academic.oup.com
Clinical evidence indicates that the fatal outcome observed with severe acute respiratory
syndrome-coronavirus-2 infection often results from alveolar injury that impedes airway …

[HTML][HTML] Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)

FY Chang, HC Chen, PJ Chen, MS Ho… - Journal of biomedical …, 2020 - Springer
Abstract On March 11, 2020, the World Health Organization declared the worldwide spread
of the infectious disease COVID-19, caused by a new strain of coronavirus, SARS-CoV-2, as …

Interrelations between COVID-19 and other disorders

A Gasmi, M Peana, L Pivina, S Srinath… - Clinical …, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …